The High Health Costs of TPP’s “Free Trade”

“This supposed ‘free trade’ agreement between the United States and 11 countries in the Americas and Asia would enshrine expansive monopoly protections for intellectual properties that shield drug makers from competition and provide them with new powers to challenge government decisions aimed at managing health care costs.” By Joseph Stiglitz.
Read more: https://medium.com/@GlobalTradeWatch/the-high-health-costs-of-tpps-free-trade-a2ed4ce09b2f#.4z5lve4go?source=Snapzu